---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

secured: "3eEHriv2LORc9XwoQpu4G7fde/ihvMeZP8vy/dnyI7fNyRaxf4Se7Ufh0HhdUTW+btarSlsLc4fT4ka5z1Zek7yLhUwC/QVjnarHypNQOC32yFwr2E3wOH86G763XgaRLsC2FvZI7UWsHguoUuCqs3e9i/P7uq6xJZWUvk7UDO9wFZHPClGuIUrM9MJModnGIfNILi4aS0ddlLsMGcvkNC6nVRCaD3LOUAVKoKhEvd2hURx58+luzl9TEU+zeH1HSygnmfSw2v+kEgHGzTooD9+bu9X01Ef3F2M9Zpf8EeAm24Hg+/4bF68x5UtLxBjF;O3Ygbt7pZ9ACMbtrEwnK2w=="
---

